No fee unless we recover compensation for your family Text size 833-4-ASBESTOS (833-427-2378) Free Case Review

Is malignant mesothelioma being overdiagnosed?

Our plain-English summary of Is malignant mesothelioma being overdiagnosed?, by H.J. Sobel (Ultrastructural Pathology, 1994).

You don't need the product names or old records. No fee unless we recover compensation for your family.

Call 833-4-ASBESTOS Request a review

The study

In plain English

This 1994 article was an editorial, an opinion piece by a pathologist rather than a study, and it reported no new data. The author argued that malignant mesothelioma is sometimes diagnosed when another disease is actually present. The author wrote that, in the current climate of asbestos litigation, asbestos exposure is blamed for many tumors, and that even reactive processes have been called mesothelioma. From personal experience, the author described seeing lung and other cancers, primary sarcomas, a thymoma, and a traumatic hemothorax (bleeding into the chest) labelled as mesothelioma, but gave no counts. In the author's view, this confusion led to unnecessary or improper treatment and raised costs while lowering the quality of patient care. On diagnostic methods, the author considered electron microscopy usually not useful. The author stated that a positive stain for cancer markers indicates adenocarcinoma, while a negative stain is of little value. The author concluded that until a reliable stain for mesothelioma is developed, diagnosis must depend on an experienced observer and on negative staining for DPAS and the cancer markers discussed.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

  • Design: editorial (opinion piece; no study data)
  • Exposure: Asbestos exposure discussed in general terms in relation to litigation; no fiber types, products, jobs or doses specified
  • Main results:
    • The author's opinion: even reactive (non-cancerous) processes have been called malignant mesothelioma
    • The author's personal experience, with no counts given: lung and other cancers, primary sarcomas, a thymoma, and a traumatic hemothorax had been called mesotheliomas
    • The author's opinion: this diagnostic confusion led to unnecessary or improper treatment, increased cost and diminished quality of patient care
    • The author's opinion: electron microscopy is usually not useful for the diagnosis
    • The author's opinion: positive stains for cancer markers indicate adenocarcinoma, while a negative stain is of little value
  • The authors' conclusion: The author concluded that until a reliable stain for mesothelioma is developed, diagnosis must depend on evaluation by an experienced observer and on negative reactions for DPAS and the cancer markers discussed.

Topics

The National Library of Medicine indexes this study under subjects our site covers: Mesothelioma.

Medical terms in this study, explained in our Lexicon: Malignant Mesothelioma.

Browse more research in Ultrastructural Pathology, or return to medical research.

Cited on this site

How to cite it

Cite the study

H.J. Sobel. Is malignant mesothelioma being overdiagnosed? Ultrastructural Pathology 1994;18(3):iii-iv. doi:10.3109/01913129409023200. PMID: 8066822.

Cite our summary

“Is malignant mesothelioma being overdiagnosed?” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/is-malignant-mesothelioma-being-overdiagnosed.

ACL Doc numbers and their short links never change. See how to cite the Library.

Talk with an asbestos lawyer

Start with what you remember, and we'll take it from there.

This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.